Literature DB >> 33684533

Cancer screening in China: The current status, challenges, and suggestions.

Maomao Cao1, He Li1, Dianqin Sun1, Siyi He1, Yiwen Yu1, Jiang Li1, Hongda Chen1, Jufang Shi1, Jiansong Ren1, Ni Li1, Wanqing Chen2.   

Abstract

Substantial progress has been made in cancer screening in China due to the substantial efforts of all levels of the government. Four large-scale population-based screening programs have been launched since 2005. In these programs, individuals at high risk for the most common types of cancer are screened with no cost. However, there are still wide gaps remaining between the cancer screening objectives and reality. In this review, we summarize the current status of cancer screening, identify the major achievements and challenges of cancer screening, and propose some suggested improvements based on the existing evidence. The main challenges include low participation rates, the uneven distribution of medical sources, inadequate funding, and insufficient screening quality. Some suggestions that should be considered to improve the quality of cancer screening include advertising to increase awareness, providing universal training of staff involved in screening programs, optimizing the definition of high-risk populations, integrating new technologies into cancer screening programs, and implementing appropriate management measures among individuals with positive screening results.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer surveillance; China; Early detection; Population; Primary prevention

Year:  2021        PMID: 33684533     DOI: 10.1016/j.canlet.2021.02.017

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.

Authors:  Ruyi Xia; Hongmei Zeng; Wenjun Liu; Li Xie; Mingwang Shen; Peng Li; He Li; Wenqiang Wei; Wanqing Chen; Guihua Zhuang
Journal:  JAMA Netw Open       Date:  2021-08-02

2.  Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA.

Authors:  Xiaorong Yang; Hui Chen; Shaowei Sang; Hao Chen; Lanbo Li; Xiaoyun Yang
Journal:  Front Public Health       Date:  2022-05-26

3.  Diagnostic value of artificial intelligence automatic detection systems for breast BI-RADS 4 nodules.

Authors:  Shu-Yi Lyu; Yan Zhang; Mei-Wu Zhang; Bai-Song Zhang; Li-Bo Gao; Lang-Tao Bai; Jue Wang
Journal:  World J Clin Cases       Date:  2022-01-14       Impact factor: 1.337

4.  Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020.

Authors:  Shaoyuan Lei; Rongshou Zheng; Siwei Zhang; Shaoming Wang; Ru Chen; Kexin Sun; Hongmei Zeng; Jiachen Zhou; Wenqiang Wei
Journal:  Cancer Commun (Lond)       Date:  2021-08-16

5.  Colorectal Cancer Screening in China: Status, Challenges, and Prospects - China, 2022.

Authors:  Hongda Chen; Bin Lu; Min Dai
Journal:  China CDC Wkly       Date:  2022-04-15

6.  Microsimulation Model for Prevention and Intervention of Coloretal Cancer in China (MIMIC-CRC): Development, Calibration, Validation, and Application.

Authors:  Bin Lu; Le Wang; Ming Lu; Yuhan Zhang; Jie Cai; Chenyu Luo; Hongda Chen; Min Dai
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

7.  Effects of population aging on the mortality burden of related cancers in urban and rural areas of China, 2004-2017: a population-based study.

Authors:  Yali Chen; Cuihong Yang; Ning Li; Zixing Wang; Peng Wu; Jin Du; Jingmei Jiang
Journal:  Cancer Biol Med       Date:  2022-03-02       Impact factor: 5.347

8.  Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea.

Authors:  Na Liu; Da-Wei Yang; Yan-Xia Wu; Wen-Qiong Xue; Dan-Hua Li; Jiang-Bo Zhang; Yong-Qiao He; Wei-Hua Jia
Journal:  BMC Cancer       Date:  2022-07-29       Impact factor: 4.638

Review 9.  Reduced Cancer Screening Due to Lockdowns of the COVID-19 Pandemic: Reviewing Impacts and Ways to Counteract the Impacts.

Authors:  Tuan Luu
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

10.  A Primary Screening Method for Liver Cancer in Chronic Hepatitis B Carriers: A Prospective Community-Based Cohort Study.

Authors:  Maomao Cao; He Li; Dianqin Sun; Siyi He; Changfa Xia; Lin Lei; Ji Peng; Wanqing Chen
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.